Moreover, they suggest putative interactions between FGF23 and inflammatory regulatory pathways due to its association with comorbidities of psoriasis like insulin resistance, dyslipidemia, atherosclerosis, or markers of chronic inflammation like interleukin-6, CRP, TNFα, and fibrinogen. The gene discussed is TNF; the disease is atherosclerosis.